Literature DB >> 8389327

delta-9-Tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of Bacillus Calmétte-Guérin-activated macrophages.

D Burnette-Curley1, F Marciano-Cabral, K Fischer-Stenger, G A Cabral.   

Abstract

The effect of delta-9-tetrahydrocannabinol (delta-9-THC), the major psychoactive component of marijuana, on the capacity of Bacillus Calmétte-Guérin (BCG)-activated macrophages to lyse L929 tumor cells, Naegleria fowleri amoebae, and herpes simplex virus-infected cells was examined. Delta-9-THC inhibited tumoricidal and amoebicidal activity in a dose-related manner. Antiviral activity was decreased when mice received 25 and 50 mg/kg delta-9-THC. The cannabinoid did not directly suppress the activation of macrophages as determined by levels of 5'-nucleotidase activity and did not inhibit splenic T-lymphocytes of BCG-recipient mice from producing interferon gamma. Nomarski optics microscopy, scanning electron microscopy, and radiolabeling binding studies demonstrated that macrophages from delta-9-THC-treated mice retained their capacity to attach to their targets. These results suggest that delta-9-THC suppresses cell contact-dependent amoebicidal, tumoricidal, and antiviral activities of activated macrophages at a stage following effector cell-target cell conjugation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389327     DOI: 10.1016/0192-0561(93)90048-4

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  9 in total

Review 1.  Drugs of abuse, immune modulation, and AIDS.

Authors:  Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-28       Impact factor: 4.147

Review 2.  Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation.

Authors:  Guy A Cabral; LaToya Griffin-Thomas
Journal:  Expert Rev Mol Med       Date:  2009-01-20       Impact factor: 5.600

Review 3.  Marijuana. Respiratory tract effects.

Authors:  B E Van Hoozen; C E Cross
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

4.  The cannabinoid receptors agonist WIN55212-2 inhibits macrophageal differentiation and alters expression and phosphorylation of cell cycle control proteins.

Authors:  Katrin Paulsen; Svantje Tauber; Johanna Timm; Nadine Goelz; Claudia Dumrese; Alexandra Stolzing; Ralf Hass; Oliver Ullrich
Journal:  Cell Commun Signal       Date:  2011-12-28       Impact factor: 5.712

5.  Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptors.

Authors:  Jakub Fichna; Misha Bawa; Ganesh A Thakur; Ritesh Tichkule; Alexandros Makriyannis; Donna-Marie McCafferty; Keith A Sharkey; Martin Storr
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

Review 6.  The Immune Endocannabinoid System of the Tumor Microenvironment.

Authors:  Melanie Kienzl; Julia Kargl; Rudolf Schicho
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

Review 7.  Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.

Authors:  Thomas W Klein; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

8.  Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function.

Authors:  Guy A Cabral; Thomas J Rogers; Aron H Lichtman
Journal:  J Neuroimmune Pharmacol       Date:  2015-06-09       Impact factor: 4.147

9.  Anti-Inflammatory, Antioxidative, and Hepatoprotective Effects of Trans Δ9-Tetrahydrocannabinol/Sesame Oil on Adjuvant-Induced Arthritis in Rats.

Authors:  Morouj Ismail; Hiba Hasan; Youmna El-Orfali; Hanan Ismail; Ghada Khawaja
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-25       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.